About Innoviva
Innoviva is a company based in Brisbane (United States) founded in 1996.. The company has 127 employees as of December 31, 2024. Innoviva has completed 2 acquisitions, including Entasis Therapeutics and La Jolla Pharmaceutical. Innoviva offers products and services including Royalty Portfolio and Critical Care Platform. Innoviva operates in a competitive market with competitors including Landos Biopharma, Theron Pharma, Maibo Pharmaceutical, Arcede Pharma and Arum Therapeutics, among others.
- Headquarter Brisbane, United States
- Employees 127 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Innoviva, Inc.
-
Annual Revenue
$372.51 M14.88as on Dec 31, 2024
-
Net Profit
$23.39 M-86.98as on Dec 31, 2024
-
EBITDA
$206.72 M38.19as on Dec 31, 2024
-
Latest Funding Round
$261 M (USD), Post-IPO
Apr 01, 2022
-
Investors
Goldman Sachs
& 1 more
-
Employee Count
127
as on Dec 31, 2024
-
Investments & Acquisitions
Entasis Therapeutics
& 1 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Innoviva
Innoviva is a publicly listed company on the NASDAQ with ticker symbol INVA in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Innoviva
Innoviva offers a comprehensive portfolio of products and services, including Royalty Portfolio and Critical Care Platform. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Manages royalties from healthcare products and therapies
Supports growth in infectious disease treatments and assets
Unlock access to complete
Unlock access to complete
Funding Insights of Innoviva
- Total Funding Total Funding
- Total Rounds 2
- Last Round Post-IPO — $261.0M
-
First Round
First Round
(07 Aug 2017)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2022 | Amount | Post-IPO - Innoviva | Valuation |
investors |
|
| Aug, 2017 | Amount | Post-IPO - Innoviva | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Innoviva
Innoviva has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Goldman Sachs and Moelis & Company. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment banking services are delivered across multiple financial sectors.
|
Founded Year | Domain | Location | |
|
Advisory services in M&A, restructuring, and capital raising are offered.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Innoviva
Innoviva has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Entasis Therapeutics and La Jolla Pharmaceutical. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Small molecules for drug-resistant bacterial infections are developed.
|
2015 | ||||
|
Developer of therapies for treating hemochromatosis & beta thalassemia
|
1989 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Innoviva
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Innoviva Comparisons
Competitors of Innoviva
Innoviva operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Landos Biopharma, Theron Pharma, Maibo Pharmaceutical, Arcede Pharma and Arum Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Small molecule therapeutics for autoimmune diseases are developed.
|
|
| domain | founded_year | HQ Location |
Specialty drugs for chronic respiratory diseases are developed.
|
|
| domain | founded_year | HQ Location |
Drugs for cancer and autoimmune diseases are developed.
|
|
| domain | founded_year | HQ Location |
Develops patent-protected drugs for chronic respiratory diseases via collaborations and research.
|
|
| domain | founded_year | HQ Location |
Therapeutics for cancer and respiratory diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Innoviva
Frequently Asked Questions about Innoviva
When was Innoviva founded?
Innoviva was founded in 1996 and raised its 1st funding round 21 years after it was founded.
Where is Innoviva located?
Innoviva is headquartered in Brisbane, United States. It is registered at Brisbane, California, United States.
Who is the current CEO of Innoviva?
Pavel Raifeld is the current CEO of Innoviva.
How many employees does Innoviva have?
As of Dec 31, 2024, the latest employee count at Innoviva is 127.
What is the annual revenue of Innoviva?
Annual revenue of Innoviva is $372.51M as on Dec 31, 2024.
What does Innoviva do?
Innoviva was founded in 1996 in Brisbane, United States, within the pharmaceutical sector focused on respiratory conditions. Prescription drugs are developed through in-licensing partnerships with Glaxo Group. Operations center on inhaled therapies, including RelvarBreoEllipta as a combination respiratory drug and AnoroEllipta as a dual bronchodilator, both targeted at managing chronic obstructive pulmonary disease.
Who are the top competitors of Innoviva?
Innoviva's top competitors include Landos Biopharma, Maibo Pharmaceutical and Theron Pharma.
What products or services does Innoviva offer?
Innoviva offers Royalty Portfolio and Critical Care Platform.
Is Innoviva publicly traded?
Yes, Innoviva is publicly traded on NASDAQ under the ticker symbol INVA.
How many acquisitions has Innoviva made?
Innoviva has made 2 acquisitions, including Entasis Therapeutics, and La Jolla Pharmaceutical.
Who are Innoviva's investors?
Innoviva has 2 investors. Key investors include Goldman Sachs, and Moelis & Company.
What is Innoviva's ticker symbol?
The ticker symbol of Innoviva is INVA on NASDAQ.